Hein Heidbüchel

87.3k total citations · 6 hit papers
352 papers, 13.7k citations indexed

About

Hein Heidbüchel is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Hein Heidbüchel has authored 352 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 297 papers in Cardiology and Cardiovascular Medicine, 38 papers in Surgery and 38 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Hein Heidbüchel's work include Atrial Fibrillation Management and Outcomes (139 papers), Cardiac Arrhythmias and Treatments (128 papers) and Cardiac electrophysiology and arrhythmias (87 papers). Hein Heidbüchel is often cited by papers focused on Atrial Fibrillation Management and Outcomes (139 papers), Cardiac Arrhythmias and Treatments (128 papers) and Cardiac electrophysiology and arrhythmias (87 papers). Hein Heidbüchel collaborates with scholars based in Belgium, Australia and Germany. Hein Heidbüchel's co-authors include André La Gerche, Jonas Oldgren, Paulus Kirchhof, Hans‐Christoph Diener, Matthias Antz, Peter Verhamme, Peter Sinnaeve, David L. Prior, Marco Alings and Werner Hacke and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Hein Heidbüchel

329 papers receiving 13.3k citations

Hit Papers

2016 ESC Guidelines for t... 2011 2026 2016 2021 2016 2015 2013 2011 2012 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. 2016 ESC Guidelines for the Management of Atrial Fibrillation Developed in Collaboration With EACTS
    2016 1.5k citations Paulus Kirchhof, Hans‐Christoph Diener et al. profile →
  2. Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
    2015 745 citations Hein Heidbüchel, Peter Verhamme et al. EP Europace profile →
  3. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation
    2013 570 citations Hein Heidbüchel, Peter Verhamme et al. EP Europace profile →
  4. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes
    2011 534 citations André La Gerche, Hein Heidbüchel et al. European Heart Journal profile →
  5. Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin
    2012 399 citations Jeff S. Healey, John W. Eikelboom et al. Circulation profile →
  6. Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure
    2021 141 citations A. John Camm, Hein Heidbüchel et al. Circulation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hein Heidbüchel Belgium 59 11.9k 2.0k 1.6k 1.3k 1.2k 352 13.7k
Peter M. Okin United States 60 11.4k 1.0× 528 0.3× 3.2k 1.9× 1.6k 1.3× 1.2k 1.0× 266 14.0k
Béla Merkely Hungary 52 10.1k 0.8× 601 0.3× 2.8k 1.7× 3.8k 3.0× 2.0k 1.6× 901 15.3k
Juhani Airaksinen Finland 62 11.0k 0.9× 808 0.4× 1.8k 1.1× 3.1k 2.4× 1.5k 1.3× 474 14.6k
Paulus Kirchhof Germany 75 23.0k 1.9× 3.2k 1.7× 1.4k 0.8× 2.3k 1.8× 778 0.7× 554 26.1k
L. Samüel Wann United States 45 18.4k 1.5× 3.2k 1.7× 2.4k 1.5× 2.3k 1.8× 1.3k 1.1× 120 20.8k
Jonathan M. Kalman Australia 78 22.2k 1.9× 671 0.3× 1.6k 1.0× 1.9k 1.5× 1.2k 1.0× 439 24.0k
Joseph E. Marine United States 56 11.6k 1.0× 361 0.2× 1.4k 0.9× 2.9k 2.3× 1.2k 1.0× 230 13.4k
David A. Cox United States 68 12.2k 1.0× 1.4k 0.7× 5.2k 3.2× 9.8k 7.7× 2.4k 2.0× 299 20.0k
Lluı́s Mont Spain 64 14.8k 1.2× 181 0.1× 1.8k 1.1× 1.8k 1.4× 398 0.3× 445 16.2k
Cynthia M. Tracy United States 49 20.8k 1.7× 2.9k 1.5× 2.3k 1.4× 2.2k 1.7× 954 0.8× 105 22.7k

Countries citing papers authored by Hein Heidbüchel

Since Specialization
Citations

This map shows the geographic impact of Hein Heidbüchel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hein Heidbüchel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hein Heidbüchel more than expected).

Fields of papers citing papers by Hein Heidbüchel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hein Heidbüchel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hein Heidbüchel. The network helps show where Hein Heidbüchel may publish in the future.

Co-authorship network of co-authors of Hein Heidbüchel

This figure shows the co-authorship network connecting the top 25 collaborators of Hein Heidbüchel. A scholar is included among the top collaborators of Hein Heidbüchel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hein Heidbüchel. Hein Heidbüchel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Desteghe, Lien, Michiel Delesie, Johan Vijgen, et al.. (2025). Effectiveness of the AF-EduCare and AF-EduApp approach to improve atrial fibrillation knowledge and risk factor awareness in patients with atrial fibrillation: a randomized controlled trial. European Journal of Cardiovascular Nursing. 24(2). 266–276. 1 indexed citations
2.
3.
Janssens, Kristel, Stephen Foulkes, Paolo D’Ambrosio, et al.. (2025). Diagnostic accuracy of different exercise blood pressure metrics in identifying hypertension on 24-h ambulatory blood pressure monitoring in athletes. Journal of Human Hypertension. 40(1). 10–17.
4.
Buck, Emmy De, et al.. (2024). The impact of different recovery positions on the perfusion of the lower forearm and comfort: A cross-over randomized controlled trial. Resuscitation Plus. 19. 100722–100722. 1 indexed citations
5.
Bergonti, Marco, Lorenzo Marcon, C Bellas, et al.. (2024). Characterization of patients with extensive left atrial myopathy referred for atrial fibrillation ablation: incidence, predictors, and outcomes. Clinical Research in Cardiology. 114(1). 126–137.
6.
Desteghe, Lien, Michiel Delesie, Johan Verbeeck, et al.. (2024). Effect of targeted education of patients with atrial fibrillation on unplanned cardiovascular outcomes: results of the multicentre randomized AF-EduCare trial. EP Europace. 27(1). 2 indexed citations
7.
Tousseyn, Thomas, et al.. (2023). Addendum: B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: a case report. Frontiers in Oncology. 13. 2 indexed citations
8.
Bergonti, Marco, Francesco Raffaele Spera, Johan Saenen, et al.. (2021). Etiology and Outcome of Catheter Ablation in Patients With Onset of Atrial Fibrillation <45 Years of Age. The American Journal of Cardiology. 166. 45–52. 8 indexed citations
9.
Claeys, Mathias, Guido Claessen, Piet Claus, et al.. (2019). Right ventricular strain rate during exercise accurately identifies male athletes with right ventricular arrhythmias. European Heart Journal - Cardiovascular Imaging. 21(3). 282–290. 16 indexed citations
10.
Hohnloser, Stefan H., A. John Camm, Riccardo Cappato, et al.. (2018). Uninterrupted administration of edoxaban vs vitamin K antagonists in patients undergoing atrial fibrillation catheter ablation: Rationale and design of the ELIMINATE‐AF study.. Clinical Cardiology. 41(4). 440–449. 8 indexed citations
11.
Konieczyńska, Małgorzata, Agata Hanna Bryk, Maciej Dębski, et al.. (2018). Differences in knowledge among patients with atrial fibrillation receiving non-vitamin K antagonist oral anticoagulants and vitamin K antagonists. Kardiologia Polska. 76(7). 1089–1096. 25 indexed citations
12.
Verma, Atul, Andrew C.T. Ha, Paulus Kirchhof, et al.. (2017). The Optimal Anti-Coagulation for Enhanced-Risk Patients Post–Catheter Ablation for Atrial Fibrillation (OCEAN) trial. American Heart Journal. 197. 124–132. 42 indexed citations
13.
Heidbüchel, Hein, Peter Verhamme, Marco Alings, et al.. (2016). Updated European Heart Rhythm Association practical guide on the use of non-vitamin-K antagonist anticoagulants in patients with non-valvular atrial fibrillation: Executive summary. European Heart Journal. 38(27). ehw058–ehw058. 188 indexed citations
14.
Heidbüchel, Hein, Peter Verhamme, Marco Alings, et al.. (2015). Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation. EP Europace. 17(10). 1467–1507. 745 indexed citations breakdown →
15.
Claessen, Guido, André La Gerche, Steven Dymarkowski, et al.. (2015). Pulmonary Vascular and Right Ventricular Reserve in Patients With Normalized Resting Hemodynamics After Pulmonary Endarterectomy. Journal of the American Heart Association. 4(3). e001602–e001602. 77 indexed citations
16.
Healey, Jeff S., John W. Eikelboom, James D. Douketis, et al.. (2012). Periprocedural Bleeding and Thromboembolic Events With Dabigatran Compared With Warfarin. Circulation. 126(3). 343–348. 399 indexed citations breakdown →
17.
Claessen, Guido, André La Gerche, Alexander Van De Bruaene, et al.. (2012). Biventricular filling impairment limits cardiac performance during exercise in healthy subjects. European Heart Journal. 33. 662–662. 1 indexed citations
18.
Pelliccia, Antonio, et al.. (2005). Recommendations for competitive sports participation in athletes with cardiovascular disease: - a consensus document from the Study group of sports cardiology of the Working group of myocardial and pericardial diseases of the European society of cardiology. Medicina dello Sport. 58(3). 157–191. 2 indexed citations
19.
Antman, EM, et al.. (2001). Enoxaparin with or without GPIIb/IIIa inhibition as reperfusion strategy in ST-segment elevation MI - results of the ENTIRE-TIMI 23 trial. European Heart Journal. 22. 15–15. 1 indexed citations
20.
Vanhees, Luc, Dirk Schepers, Hein Heidbüchel, Johan Defoor, & R. Fagard. (2001). Exercise performance and training in patients with implantable cardioverter-defibrillators and coronary heart disease. The American Journal of Cardiology. 87(6). 712–715. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter M. Okin Breakdown of academic impact, for papers by Béla Merkely Breakdown of academic impact, for papers by Juhani Airaksinen Breakdown of academic impact, for papers by Paulus Kirchhof Breakdown of academic impact, for papers by L. Samüel Wann Breakdown of academic impact, for papers by Jonathan M. Kalman Breakdown of academic impact, for papers by Joseph E. Marine Breakdown of academic impact, for papers by David A. Cox Breakdown of academic impact, for papers by Lluı́s Mont Breakdown of academic impact, for papers by Cynthia M. Tracy
Rankless by CCL
2026